• Nenhum resultado encontrado

[PDF] Top 20 Rev. Bras. Ginecol. Obstet. vol.38 número11

Has 10000 "Rev. Bras. Ginecol. Obstet. vol.38 número11" found on our website. Below are the top 20 most common "Rev. Bras. Ginecol. Obstet. vol.38 número11".

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... 3 Shah AD, Kohli N, Rajan SS, Hoyte L. The age distribution, rates, and types of surgery for stress urinary incontinence in the USA. Int Urogynecol J Pelvic Floor Dysfunct 2008;19(1):89–96 4 Wu JM, Kawasaki A, Hundley ... See full document

2

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... Prospective, randomized, double-blind study of the ef fi cacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OP[r] ... See full document

12

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... Item 4 (“I regret it”) of the STAI S-Anxiety scale did not have a representative statistical value, and it was excluded from the analysis. This mathematical result is a clinical reflex of the circumstances of the ... See full document

7

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... In a study of 29 doctors and nurses providing prenatal care in the city of Rio Grande, 58.7% of those surveyed reported providing guidance to pregnant wom- en regarding toxoplasmosis.. H[r] ... See full document

7

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... 5 A study involving 10,000 women showed that the methods with most rates of unintended pregnancy are patch, ring, oral and injectable.. It shows that the cause most related with the fail[r] ... See full document

7

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... 7 As seen in the present study, Karmon et al 25 found similar clinical pregnancy and delivery rates among women with TSH concentrations of 0.4 – 2.49 mIU/L and 2.5 – 4.99 mIU/L undergoin[r] ... See full document

7

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... Sexual function was evaluated by means of the Female Sexual Function Index (FSFI), and all domains were analyzed (desire, arousal, lubrication, orgasm, satisfaction, and pain).. Initiall[r] ... See full document

5

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... A 38 year-old woman with a spontaneous monochorionic, diamniotic twin pregnancy was referred to our institution at 9 weeks for a multiple pregnancy follow-up. Her personal medical history included ankylosing ... See full document

4

Rev. Bras. Ginecol. Obstet.  vol.38 número11

Rev. Bras. Ginecol. Obstet. vol.38 número11

... Address for correspondence Jakob Triebel, MD, Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital & Paracelsus Medical Universi[r] ... See full document

2

Rev. Bras. Ginecol. Obstet.  vol.36 número11

Rev. Bras. Ginecol. Obstet. vol.36 número11

... Como dispomos largamente na literatura de dados dopplervelocimétricos du- rante a gestação de todos os seguimentos vasculares analisados nessa pesquisa e todos foram realizados em repou[r] ... See full document

2

Rev. Bras. Ginecol. Obstet.  vol.39 número11

Rev. Bras. Ginecol. Obstet. vol.39 número11

... the delivery beyond 34 weeks, there is a considerable improvement in perinatal outcomes. The study by Pettit et al, which had a significant number of cases (n ¼ 696), 13 showed that the women who developed early-onset ... See full document

10

Rev. Bras. Ginecol. Obstet.  vol.36 número11

Rev. Bras. Ginecol. Obstet. vol.36 número11

... Além disso, nesse estudo a ausência de um Grupo Controle, preferencialmente randomizado, para não gerar viés de seleção dos sujeitos de pesquisa, seria fundamental para responder à per[r] ... See full document

2

Rev. Bras. Ginecol. Obstet.  vol.36 número11

Rev. Bras. Ginecol. Obstet. vol.36 número11

... PURPOSE: To evaluate variations in the body mass index in patients undergoing adjuvant chemotherapy for breast cancer, and to associate these changes with patient’s age and adjuvant ch[r] ... See full document

6

Rev. Bras. Ginecol. Obstet.  vol.37 número11

Rev. Bras. Ginecol. Obstet. vol.37 número11

... Means and standard deviations for chemotactic activity (migration distances expressed in μ) and phagocytosis ingestion phase by neutrophilic polymorphonuclear leukocytes (percentage in[r] ... See full document

4

Rev. Bras. Ginecol. Obstet.  vol.37 número11

Rev. Bras. Ginecol. Obstet. vol.37 número11

... 24. Marenco ML, Márquez J, Ontanilla A, García-Díaz L, Rivero M, Losada A, et al. [Intrauterine myelomeningocele repair: experience of the fetal medicine and therapy program of the Virgen de Rocío University Hospital]. ... See full document

3

Rev. Bras. Ginecol. Obstet.  vol.39 número11

Rev. Bras. Ginecol. Obstet. vol.39 número11

... The associated diseases may explain this high number of patients with vasomotor symptoms: we observed a large number of women with systematic arterial hypertension and diabetes mellitus.[r] ... See full document

6

Rev. Bras. Ginecol. Obstet.  vol.37 número11

Rev. Bras. Ginecol. Obstet. vol.37 número11

... pregnant women with preeclampsia diagnosed in accordance with the Report of the American National High Blood Pressure Education Program 2 , and the control group (n=115), comprising w[r] ... See full document

4

Rev. Bras. Ginecol. Obstet.  vol.39 número11

Rev. Bras. Ginecol. Obstet. vol.39 número11

... 11 Maeda SS, Borba VZ, Camargo MB, et al; Brazilian Society of En- docrinology and Metabology (SBEM). Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of ... See full document

2

Rev. Bras. Ginecol. Obstet.  vol.39 número11

Rev. Bras. Ginecol. Obstet. vol.39 número11

... In relation to the type of healthcare service where the delivery occurred, we found higher prevalence rates among those women who received care in public health services. However, it is [r] ... See full document

9

Rev. Bras. Ginecol. Obstet.  vol.39 número11

Rev. Bras. Ginecol. Obstet. vol.39 número11

... Conclusion We were unable to fi rmly establish the clinical or sonographic parameters associated with adverse fetal outcomes in patients with parvovirus infection managed with intrauterin[r] ... See full document

6

Show all 10000 documents...